[Clinical significance of the use-dependent sodium channel block and reverse use-dependent potassium channel block of class I and class III antiarrhythmic agents and their values to predict drug efficacy]

Jpn Circ J. 1992:56 Suppl 5:1474-6. doi: 10.1253/jcj.56.supplementv_1474.
[Article in Japanese]
No abstract available

MeSH terms

  • Anti-Arrhythmia Agents / pharmacology
  • Anti-Arrhythmia Agents / therapeutic use*
  • Arrhythmias, Cardiac / drug therapy*
  • Arrhythmias, Cardiac / physiopathology
  • Disopyramide / therapeutic use
  • Drug Evaluation
  • Electrocardiography, Ambulatory*
  • Electrophysiology
  • Exercise Test
  • Humans
  • Lidocaine / analogs & derivatives
  • Lidocaine / therapeutic use
  • Mexiletine / therapeutic use
  • Middle Aged
  • Potassium Channels / drug effects*
  • Sodium Channels / drug effects*

Substances

  • Anti-Arrhythmia Agents
  • Potassium Channels
  • Sodium Channels
  • Mexiletine
  • Lidocaine
  • pilsicainide
  • Disopyramide